<code id='E2F75A00FE'></code><style id='E2F75A00FE'></style>
    • <acronym id='E2F75A00FE'></acronym>
      <center id='E2F75A00FE'><center id='E2F75A00FE'><tfoot id='E2F75A00FE'></tfoot></center><abbr id='E2F75A00FE'><dir id='E2F75A00FE'><tfoot id='E2F75A00FE'></tfoot><noframes id='E2F75A00FE'>

    • <optgroup id='E2F75A00FE'><strike id='E2F75A00FE'><sup id='E2F75A00FE'></sup></strike><code id='E2F75A00FE'></code></optgroup>
        1. <b id='E2F75A00FE'><label id='E2F75A00FE'><select id='E2F75A00FE'><dt id='E2F75A00FE'><span id='E2F75A00FE'></span></dt></select></label></b><u id='E2F75A00FE'></u>
          <i id='E2F75A00FE'><strike id='E2F75A00FE'><tt id='E2F75A00FE'><pre id='E2F75A00FE'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:3354
          Richard Burr
          North Carolina Senator Richard Burr received strong support from the biotech sector. Gerry Broome/AP

          WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

          North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

          advertisement

          Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Why Eli Lilly’s earnings didn’t quite live up to the hype
          Why Eli Lilly’s earnings didn’t quite live up to the hype

          KristofferTripplaar/APEventually,theluckiestcompaniesgettodealwithaveryparticularproblem:whattodowhe

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Having children helps parents live longer, especially after age 80

          SeanGallup/GettyImagesGutChecklooksathealthclaimsmadebystudies,newsmakers,orconventionalwisdom.Weask